EP2224973A4 - Preservatives for cosmetic, toiletry and pharmaceutical compositions - Google Patents
Preservatives for cosmetic, toiletry and pharmaceutical compositionsInfo
- Publication number
- EP2224973A4 EP2224973A4 EP08854415A EP08854415A EP2224973A4 EP 2224973 A4 EP2224973 A4 EP 2224973A4 EP 08854415 A EP08854415 A EP 08854415A EP 08854415 A EP08854415 A EP 08854415A EP 2224973 A4 EP2224973 A4 EP 2224973A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- toiletry
- preservatives
- cosmetic
- pharmaceutical compositions
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000003755 preservative agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
- A01N37/28—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the group; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16162654.4A EP3075401B1 (en) | 2007-11-29 | 2008-11-26 | Preservation for cosmetic, toiletry and pharmaceutical compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US476007P | 2007-11-29 | 2007-11-29 | |
PCT/US2008/084983 WO2009070736A1 (en) | 2007-11-29 | 2008-11-26 | Preservatives for cosmetic, toiletry and pharmaceutical compositions |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16162654.4A Division EP3075401B1 (en) | 2007-11-29 | 2008-11-26 | Preservation for cosmetic, toiletry and pharmaceutical compositions |
EP16157775 Division-Into | 2016-02-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2224973A1 EP2224973A1 (en) | 2010-09-08 |
EP2224973A4 true EP2224973A4 (en) | 2012-07-04 |
EP2224973B1 EP2224973B1 (en) | 2016-04-20 |
Family
ID=40676404
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16162654.4A Active EP3075401B1 (en) | 2007-11-29 | 2008-11-26 | Preservation for cosmetic, toiletry and pharmaceutical compositions |
EP08854415.0A Revoked EP2224973B1 (en) | 2007-11-29 | 2008-11-26 | Preservatives for cosmetic, toiletry and pharmaceutical compositions |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16162654.4A Active EP3075401B1 (en) | 2007-11-29 | 2008-11-26 | Preservation for cosmetic, toiletry and pharmaceutical compositions |
Country Status (5)
Country | Link |
---|---|
US (7) | US8993641B2 (en) |
EP (2) | EP3075401B1 (en) |
ES (1) | ES2582555T3 (en) |
PL (1) | PL2224973T3 (en) |
WO (1) | WO2009070736A1 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2370220B1 (en) | 2010-05-19 | 2012-10-19 | José Antonio Novejarque Conde | FORMULATION FOR THE CONSERVATION OF COSMETIC PRODUCTS. |
FR2976806B1 (en) * | 2011-06-22 | 2013-06-28 | Urgo Lab | FILMOGENIC TOPICAL COMPOSITION AND USE THEREOF FOR THE TREATMENT OF MYCOSES |
KR101217717B1 (en) | 2011-10-07 | 2013-01-02 | 배은경 | Moisturizing and antiseptic compositions |
DE102011088934A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Active ingredient combinations of one or more polyols and one or more physiologically acceptable hydroxamic acids, as well as cosmetic or dermatological preparations containing such active substance combinations |
DE102011088951A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Active ingredient combinations of one or more aromatic alcohols and one or more physiologically acceptable hydroxamic acids and cosmetic or dermatological preparations containing such active ingredient combinations |
DE102011088944A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Active agent combination, useful e.g. to combat or prevent Staphylococcus aureus and as antibacterial, antimycotic or antiviral agents, comprises hydroxamic acids and silver compounds |
DE102011088962A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Active ingredient combinations of one or more carboxylic acids, in particular hydroxycarboxylic acids, and one or more physiologically acceptable hydroxamic acid and cosmetic or dermatological preparations containing such active ingredient combinations |
DE102011088926A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Hairstyling formulation to create a flexible hold by using octanohydroxamic acid |
DE102011088936A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Active ingredient combinations of one or more alkyl ethers of glycerol and one or more physiologically acceptable hydroxamic acids, as well as cosmetic or dermatological preparations containing such drug combinations |
DE102011088957A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Active ingredient combinations of piroctone olamine and one or more physiologically harmless hydroxamic acid and cosmetic or dermatological preparations containing such drug combinations |
DE102011088931A1 (en) | 2011-12-19 | 2013-06-20 | Beiersdorf Ag | Use of hydroxamic acids for stabilizing cosmetic and / or dermatological preparations |
US8853189B2 (en) | 2012-05-31 | 2014-10-07 | Prima Innovations, Llc | Antispasmodic 1,2-Diols and 1,2,3-triols |
CN102920612A (en) * | 2012-07-02 | 2013-02-13 | 南京斯拜科生化实业有限公司 | Broad-spectrum antibacterial cosmetic antiseptic and application thereof |
MX354696B (en) | 2013-06-27 | 2018-03-15 | Procter & Gamble | Personal care articles. |
FR3019552B1 (en) * | 2014-04-03 | 2016-04-01 | Urgo Lab | FILMOGENE COMPOSITION |
JP6709585B2 (en) * | 2014-08-19 | 2020-06-17 | ロート製薬株式会社 | Topical skin |
US10117820B2 (en) | 2015-06-02 | 2018-11-06 | Ajinomoto Co., Inc. | Cosmetic composition |
MX2018000538A (en) * | 2015-07-14 | 2018-05-22 | Unilever Nv | Antimicrobial composition. |
CN105362140B (en) * | 2015-11-28 | 2018-09-25 | 广东轻工职业技术学院 | A kind of non-cosmetics preservative composition and its application with preservative efficacy |
CN105411923B (en) * | 2015-12-03 | 2018-11-02 | 南京斯拜科生化实业有限公司 | Natural broad spectrum preservation composition containing grapefruit seed extract and its application |
JP6157659B1 (en) * | 2016-02-10 | 2017-07-05 | イノレックス インベストメント コーポレイション | Synergistic compositions, formulations and related methods for reducing UV-induced lipid peroxidation |
CN105997545B (en) * | 2016-06-30 | 2018-03-20 | 广州艾卓生物科技有限公司 | Compositional antiseptic agent containing glycerol caprylate and decoyl hydroximic acid and preparation method thereof |
WO2018101370A1 (en) * | 2016-11-30 | 2018-06-07 | 味の素株式会社 | Acyl amino acid-rich composition |
JP7039968B2 (en) * | 2016-11-30 | 2022-03-23 | 味の素株式会社 | Acyl amino acid high compound composition |
AU2017420730B2 (en) | 2017-06-29 | 2023-12-14 | Kimberly-Clark Worldwide, Inc. | Antimicrobial composition including a dihydroxamic acid and methods of inhibiting microbial growth utilizing the same |
BR112019027713B1 (en) * | 2017-06-30 | 2023-03-21 | L'oreal | ANTIMICROBIAL MIXTURE, COMPOSITION AND USE OF AN ANTIMICROBIAL MIXTURE |
FR3073396B1 (en) * | 2017-11-10 | 2020-11-06 | Oreal | ANTIMICROBIAL MIXTURE CONTAINING 4- (3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE AND A HYDROXAMIC ACID, AND COSMETIC COMPOSITION CONTAINING THE SAME |
US10603152B2 (en) | 2017-08-31 | 2020-03-31 | Kimberly-Clark Worldwide, Inc. | Multi-component vaginal insert |
US10959975B1 (en) * | 2017-11-02 | 2021-03-30 | The Tetra Corporation | Antifungal composition, method of making composition, and method of using composition |
CN111655293A (en) * | 2017-11-16 | 2020-09-11 | 艾维塔生物医学公司 | Use of cell membrane-bound signaling factors |
EP3758671A4 (en) * | 2018-01-30 | 2022-03-30 | Inolex Investment Corporation | Natural 1,2-alkanediols, compositions having natural 1,2-alkanediols and processes for making the same |
JP2020002032A (en) * | 2018-06-26 | 2020-01-09 | 株式会社Adeka | Antimicrobial composition, and cosmetics containing antimicrobial composition |
US10603151B2 (en) | 2018-08-27 | 2020-03-31 | Kimberly-Clark Worldwide, Inc. | Multi-component vaginal insert |
US20200095521A1 (en) * | 2018-09-20 | 2020-03-26 | Inolex Investment Corporation | Shelf Stable Formulations for Home, Institution and Industrial Uses |
CN111012698A (en) * | 2020-01-09 | 2020-04-17 | 厦门市斯维特日用品有限公司 | Bath cream for bathhouse and preparation method thereof |
EP4125791A1 (en) * | 2020-03-31 | 2023-02-08 | Minasolve SAS | Homogeneous liquid composition comprising 1,2-octanediol and use thereof |
CA3183245A1 (en) * | 2020-05-22 | 2021-11-25 | Inolex Investment Corporation | Biobased alkyl glyceryl ethers and methods of making and using the same |
WO2022122135A1 (en) * | 2020-12-09 | 2022-06-16 | Symrise Ag | Compositions comprising (bio)-alkanediols with antimicrobials for product protection |
TW202322790A (en) * | 2021-08-20 | 2023-06-16 | 美商伊諾萊克斯投資公司 | Potassium hydrogen salts of alkylhydroxamates and compositions comprising the same |
WO2023052616A1 (en) | 2021-10-01 | 2023-04-06 | Clariant International Ltd | Sugar amides and mixtures thereof |
CA3232245A1 (en) * | 2021-10-08 | 2023-04-13 | Inolex Investment Corporation | Biobased polyglyceryl esters and compositions comprising the same |
WO2023227802A1 (en) * | 2022-07-20 | 2023-11-30 | Clariant International Ltd | Antimicrobial combinations |
EP4349806A1 (en) | 2022-10-07 | 2024-04-10 | Clariant International Ltd | Bio-based antimicrobial compounds |
WO2023247803A2 (en) | 2022-12-20 | 2023-12-28 | Clariant International Ltd | Antimicrobial combinations |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0127726A1 (en) * | 1983-02-28 | 1984-12-12 | VEB Fahlberg-List Magdeburg | Hydroxamic acids, their preparation and their use in pharmaceutical compositions |
US4661342A (en) * | 1984-11-20 | 1987-04-28 | Lion Corporation | Oral compositions comprising hydroxamic acids and salts thereof |
WO1999039704A1 (en) * | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
US20060211732A1 (en) * | 1998-05-16 | 2006-09-21 | British Biotech Pharmaceuticals Ltd. | Hydroxamic acid derivatives as antibacterials |
WO2007098135A2 (en) * | 2006-02-21 | 2007-08-30 | Inolex Investment Corporation | Anti-microbial compositions |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3427316A (en) | 1966-05-02 | 1969-02-11 | Millmaster Onyx Corp | Quaternary ammonium hydroxamates |
US3632764A (en) * | 1969-12-15 | 1972-01-04 | Millmaster Onyx Corp | Alkyl-hydroxamic acids and salts thereof as anti-fungal agents |
DE2060764A1 (en) * | 1970-12-10 | 1972-06-22 | Henkel & Cie Gmbh | Synergistic, antimicrobial combinations of active ingredients and their use in antimicrobial agents |
US3978208A (en) | 1974-01-07 | 1976-08-31 | Eisai Co., Ltd. | Deodorizing compositions |
DE2644833A1 (en) * | 1976-10-05 | 1978-04-20 | Boehringer Sohn Ingelheim | NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE AMINOPROPANES AND METHOD FOR THE PRODUCTION THEREOF |
JPS6029701B2 (en) | 1978-09-18 | 1985-07-12 | エーザイ株式会社 | Novel hydroxamic acid compound, method for producing the same, and pharmaceutical containing the same |
JPS55167210A (en) | 1979-06-15 | 1980-12-26 | Kobayashi Kooc:Kk | Water-containing cosmetic |
US4871466A (en) | 1987-10-15 | 1989-10-03 | American Cyanamid Company | Novel collectors and processes for making and using same |
DE4240674C2 (en) * | 1992-11-26 | 1999-06-24 | Schuelke & Mayr Gmbh | Deodorant ingredients |
DE4429468C2 (en) | 1994-08-19 | 1998-07-09 | Beiersdorf Ag | Use of hydrophobized anorganic pigments to maintain the skin's urocanic acid status during bathing |
FR2734158B1 (en) | 1995-05-17 | 1997-06-27 | Roche Posay Lab Pharma | COMBINATION OF A COMPOUND WITH ANTI-MICROBIAL ACTIVITY AND A MONOALKYLETHER OF GLYCEROL |
US6943144B1 (en) | 1997-05-20 | 2005-09-13 | The Procter & Gamble Company | Concentrated stable, translucent or clear fabric softening compositions including chelants |
US6338855B1 (en) | 1996-10-25 | 2002-01-15 | The Procter & Gamble Company | Cleansing articles for skin and/or hair which also deposit skin care actives |
FR2767697B1 (en) * | 1997-09-01 | 2000-05-05 | Boots Co Plc | DERMATOLOGICAL COMPOSITION FOR PREVENTING THE APPEARANCE OF SKIN HYPERSENSITIVITY AND INTOLERANCE SYMPTOMS |
US6447793B2 (en) | 1998-09-16 | 2002-09-10 | The Collaborative Group, Ltd. | Water soluble, broad spectrum preservative system |
EP1206933B1 (en) * | 2000-11-16 | 2006-05-17 | Johnson & Johnson Consumer France SAS | Compositions comprising caprylyl glycol and iodopropynyl butylcarbamate |
US6846846B2 (en) * | 2001-10-23 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin disinfectants |
US20060210500A1 (en) | 2003-04-18 | 2006-09-21 | Merck Patent Gmbh | Formulations |
WO2005073074A2 (en) * | 2004-01-28 | 2005-08-11 | Rosenberg Christian F | Large-scale watercraft storage facility |
US7935732B2 (en) | 2004-04-08 | 2011-05-03 | Isp Investments Inc. | Antimicrobial compositions |
US20060008434A1 (en) * | 2004-05-25 | 2006-01-12 | Knopf Michael A | Deodorant body wash with lotion |
DE102005012123A1 (en) | 2005-03-16 | 2006-09-28 | Schülke & Mayr GmbH | Isothiazolone-containing preservative with improved effectiveness |
WO2008061187A1 (en) | 2006-11-15 | 2008-05-22 | Dupont Tate & Lyle Bio Products Company, Llc | Preservative compositions comprising renewably-based, biodegradable 1,3-propanediol |
JP2011504456A (en) | 2007-02-02 | 2011-02-10 | ディーブイビー グローバル, エルエルシー | Golden ratio harmonized water and aqueous solution |
US20080226568A1 (en) * | 2007-03-13 | 2008-09-18 | Playtex Products, Inc. | Synergistic preservative systems and their use in topical compositions |
-
2008
- 2008-11-26 US US12/324,504 patent/US8993641B2/en active Active
- 2008-11-26 PL PL08854415.0T patent/PL2224973T3/en unknown
- 2008-11-26 ES ES08854415.0T patent/ES2582555T3/en active Active
- 2008-11-26 EP EP16162654.4A patent/EP3075401B1/en active Active
- 2008-11-26 WO PCT/US2008/084983 patent/WO2009070736A1/en active Application Filing
- 2008-11-26 EP EP08854415.0A patent/EP2224973B1/en not_active Revoked
-
2011
- 2011-07-13 US US13/182,292 patent/US20110268676A1/en not_active Abandoned
-
2015
- 2015-02-05 US US14/614,815 patent/US20150148421A1/en not_active Abandoned
-
2017
- 2017-08-31 US US15/692,447 patent/US20170360035A1/en not_active Abandoned
-
2020
- 2020-02-04 US US16/781,636 patent/US11291204B2/en active Active
- 2020-07-01 US US16/918,648 patent/US10897899B2/en active Active
-
2022
- 2022-02-23 US US17/678,579 patent/US20220272973A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0127726A1 (en) * | 1983-02-28 | 1984-12-12 | VEB Fahlberg-List Magdeburg | Hydroxamic acids, their preparation and their use in pharmaceutical compositions |
US4661342A (en) * | 1984-11-20 | 1987-04-28 | Lion Corporation | Oral compositions comprising hydroxamic acids and salts thereof |
WO1999039704A1 (en) * | 1998-02-07 | 1999-08-12 | British Biotech Pharmaceuticals Limited | Antibacterial agents |
US20060211732A1 (en) * | 1998-05-16 | 2006-09-21 | British Biotech Pharmaceuticals Ltd. | Hydroxamic acid derivatives as antibacterials |
WO2007098135A2 (en) * | 2006-02-21 | 2007-08-30 | Inolex Investment Corporation | Anti-microbial compositions |
Non-Patent Citations (1)
Title |
---|
See also references of WO2009070736A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2224973A1 (en) | 2010-09-08 |
ES2582555T3 (en) | 2016-09-13 |
EP3075401A1 (en) | 2016-10-05 |
US20200170248A1 (en) | 2020-06-04 |
US20150148421A1 (en) | 2015-05-28 |
WO2009070736A1 (en) | 2009-06-04 |
US20220272973A1 (en) | 2022-09-01 |
US10897899B2 (en) | 2021-01-26 |
EP2224973B1 (en) | 2016-04-20 |
US20110268676A1 (en) | 2011-11-03 |
US20170360035A1 (en) | 2017-12-21 |
PL2224973T3 (en) | 2016-11-30 |
US20090143489A1 (en) | 2009-06-04 |
US20200329704A1 (en) | 2020-10-22 |
US8993641B2 (en) | 2015-03-31 |
US11291204B2 (en) | 2022-04-05 |
EP3075401B1 (en) | 2024-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2224973T3 (en) | Preservatives for cosmetic, toiletry and pharmaceutical compositions | |
ZA201002203B (en) | Cosmetic or pharmaceutical composition for topical application | |
HK1147278A1 (en) | Gel composition and cosmetic preparation | |
EP2135596B8 (en) | Hair cosmetic compositions | |
EP2039347A4 (en) | Cosmetic hair preparation | |
PL2200577T3 (en) | Hair care composition | |
EP2116224A4 (en) | Cosmetic composition | |
IL206808A (en) | Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof | |
HK1146235A1 (en) | Powder cosmetic composition | |
SI2606874T1 (en) | Novel cosmetic and/or pharmaceutical compositions and uses thereof | |
EP2199402A4 (en) | Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof | |
EP2241569A4 (en) | Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses | |
EP2229933A4 (en) | Hair cosmetic composition | |
EP2190445A4 (en) | Pomegranate sprouts, preparations derived therefrom and compositions comprising same | |
GB0719202D0 (en) | Compositions and methods for the skin and hair | |
IL210316A (en) | Triazole derivatives, pharmaceutical compositions comprising the same and uses thereof | |
MX303262B (en) | Lotion composition for personal use. | |
GB2479251B (en) | Cosmetic or pharmaceutical composition, in particular intended for care or for makeup | |
ZA201009097B (en) | C-ring-substituted pregn-4-ene-21,17-carbolactone,and pharmaceutical preparations comprising the latter | |
HK1135617A1 (en) | Shampoo composition | |
WO2010046061A3 (en) | Cosmetic and/or pharmaceutical formulations | |
EP2057980A4 (en) | Gel cosmetic composition | |
GB0501942D0 (en) | Cosmetic, veterinary, pharmaceutical and therapeutic compositions | |
IL212171A (en) | 1-phenylpyrrole compounds, pharmaceutical compositions comprising them and their uses | |
EP2402333A4 (en) | 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100616 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120601 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 17/04 20060101ALI20120525BHEP Ipc: C07C 35/00 20060101ALI20120525BHEP Ipc: A61K 47/16 20060101ALI20120525BHEP Ipc: A61L 101/34 20060101AFI20120525BHEP Ipc: A61Q 19/00 20060101ALI20120525BHEP Ipc: A61K 8/34 20060101ALI20120525BHEP Ipc: C07C 205/00 20060101ALI20120525BHEP Ipc: A61K 8/40 20060101ALI20120525BHEP |
|
17Q | First examination report despatched |
Effective date: 20140611 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20151023 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 791692 Country of ref document: AT Kind code of ref document: T Effective date: 20160515 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602008043780 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2582555 Country of ref document: ES Kind code of ref document: T3 Effective date: 20160913 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 791692 Country of ref document: AT Kind code of ref document: T Effective date: 20160420 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20160420 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160720 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160721 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 602008043780 Country of ref document: DE |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
26 | Opposition filed |
Opponent name: L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'E Effective date: 20170117 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
R26 | Opposition filed (corrected) |
Opponent name: L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'E Effective date: 20170117 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161130 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161130 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161126 |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20081126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160420 |
|
RDAF | Communication despatched that patent is revoked |
Free format text: ORIGINAL CODE: EPIDOSNREV1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161126 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
R26 | Opposition filed (corrected) |
Opponent name: L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'E Effective date: 20170117 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20191112 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20191202 Year of fee payment: 12 Ref country code: FR Payment date: 20191029 Year of fee payment: 12 Ref country code: IT Payment date: 20191108 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20191122 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R064 Ref document number: 602008043780 Country of ref document: DE Ref country code: DE Ref legal event code: R103 Ref document number: 602008043780 Country of ref document: DE |
|
APBU | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9O |
|
RDAG | Patent revoked |
Free format text: ORIGINAL CODE: 0009271 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT REVOKED |
|
REG | Reference to a national code |
Ref country code: FI Ref legal event code: MGE |
|
27W | Patent revoked |
Effective date: 20200915 |
|
GBPR | Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting state |
Effective date: 20200915 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20200915 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20201124 Year of fee payment: 13 |